Your browser doesn't support javascript.
loading
Management of carbapenem-resistant Acinetobacter baumannii epidemic in an intensive care unit using multifaceted intervention strategy.
Hong, Jeongmin; Jang, Ok Jeom; Bak, Mi Hui; Baek, Eun Hwa; Park, Ki-Ho; Hong, Sun In; Cho, Oh-Hyun; Bae, In-Gyu.
Afiliação
  • Hong J; Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea.
  • Jang OJ; Infection Control Office, Gyeongsang National University Hospital, Jinju, Korea.
  • Bak MH; Infection Control Office, Gyeongsang National University Hospital, Jinju, Korea.
  • Baek EH; Infection Control Office, Gyeongsang National University Hospital, Jinju, Korea.
  • Park KH; Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Korea.
  • Hong SI; Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea.
  • Cho OH; Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea.
  • Bae IG; Infection Control Office, Gyeongsang National University Hospital, Jinju, Korea.
Korean J Intern Med ; 33(5): 1000-1007, 2018 09.
Article em En | MEDLINE | ID: mdl-29172401
ABSTRACT
BACKGROUND/

AIMS:

We evaluated the effects of a multifaceted intervention for controlling a carbapenem-resistant Acinetobacter baumannii (CRAB) epidemic in an intensive care unit (ICU) with no restrictions on carbapenem use.

METHODS:

This study was conducted in a medical ICU between April 2012 and June 2016. The baseline infection control programs included surveillance cultures, contact precautions, and environmental cleaning. However, increases in the detection of CRAB isolates beginning in May 2013 led to the implementation of a new protocol, consisting of universal glove and gown use with daily chlorhexidine bathing for all patients in combination with baseline programs. The efficacy of the intervention was subjected to interrupted time series (ITS) analysis.

RESULTS:

The multifaceted intervention led to a decrease in the incidence of CRAB from 17.65 to 0.89 cases per 1,000 patient-days, during the study period (p < 0.001). ITS analysis revealed a significant change in the trend of CRAB incidence (-0.413, p < 0.001). Over this same period, mean monthly use of carbapenems increased from 143.54 ± 95.73 to 204.95 ± 78.43 doses per 1,000 patient-days (p = 0.018).

CONCLUSION:

Our multifaceted intervention reduced the incidence of CRAB acquisition in an ICU where carbapenem use was not restricted.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Acinetobacter / Carbapenêmicos / Farmacorresistência Bacteriana / Unidades de Terapia Intensiva / Antibacterianos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Acinetobacter / Carbapenêmicos / Farmacorresistência Bacteriana / Unidades de Terapia Intensiva / Antibacterianos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article